Low Cerebral Oxygen Consumption and Blood Flow in Patients With Cirrhosis and an Acute Episode of Hepatic Encephalopathy

Gastroenterology

Volumn 136, Issue 3, 2009, Pages 863-871

  Iversen, Peter ^a   Sørensen, Michael ^a   Bak, Lasse Kristoffer ^b   Waagepetersen, Helle Sønderby ^b   Vafaee, Manouchehr Seyedi ^a   Borghammer, Per ^a   Mouridsen, Kim ^a   Jensen, Svend Borup ^a   Vilstrup, Hendrik ^a   Schousboe, Arne ^b   Ott, Peter ^a   Gjedde, Albert ^a   Keiding, Susanne ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA;

ADULT; AMMONIA BLOOD LEVEL; ARTICLE; BRAIN BLOOD FLOW; BRAIN OXYGEN CONSUMPTION; CLINICAL ARTICLE; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CIRRHOSIS; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

EID: 60449114813     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2008.10.057     Document Type: Article

References (48)

1. Sherlock S., Summerskill W.H., White L.P., et al. Portal-systemic encephalopathy; neurological complications of liver disease. Lancet 267 (1954) 453-457
2. Lockwood A.H., McDonald J.M., Reiman R.E., et al. The dynamics of ammonia metabolism in man: effects of liver disease and hyperammonemia. J Clin Invest 63 (1979) 449-460
3. Cooper A.J., and Plum F. Biochemistry and physiology of brain ammonia. Physiol Rev 67 (1987) 440-519
4. Butterworth R.F., Giguere J.-F., Michaud J., et al. Ammonia: key factor in the pathogenesis of hepatic encephalopathy. Neurochem Pathol 6 (1987) 1-12
5. Jones E.A., and Basile A.S. Does ammonia contribute to increased GABA-ergic neurotransmission in liver failure?. Metab Brain Dis 13 (1998) 351-360
6. Butterworth R.F. Pathophysiology of hepatic encephalopathy: a new look at ammonia. Metab Brain Dis 17 (2002) 221-227
7. Ott P., and Larsen F.S. Blood-brain barrier permeability to ammonia in liver failure: a critical reappraisal. Neurochem Int 44 (2004) 185-198
8. Ott P., Clemmesen O., and Larsen F.S. Cerebral metabolic disturbances in the brain during acute liver failure: from hyperammonemia to energy failure and proteolysis. Neurochem Int 47 (2005) 13-18
9. Lai J.C., and Cooper A.J. Brain α-ketoglutarate dehydrogenase complex: kinetic properties, regional distribution, and effects of inhibitors. J Neurochem 47 (1986) 1376-1386
10. Zwingmann C., Chatauret N., Leibfritz D., et al. Selective increase of brain lactate synthesis in experimental acute liver failure: results of a [H-C] nuclear magnetic resonance study. Hepatology 37 (2003) 420-428
11. 13N-ammonia during acute hepatic encephalopathy in cirrhosis measured by positron emission tomography. Hepatology 43 (2006) 42-50 Correction in Hepatology 2006;44:1056
12. Johansen M.L., Bak L.K., Schousboe A., et al. The metabolic role of isoleucine in detoxification of ammonia in cultured mouse neurons and astrocytes. Neurochem Int 50 (2007) 1042-1051
13. Fazekas J.F., Ticktin H.E., Wilfred R., et al. Cerebral metabolism in hepatic insufficiency. Am J Med 21 (1956) 843-849
14. Posner J.B. The toxic effects of carbon dioxide and acetazolamide in hepatic encephalopathy. J Clin Invest 39 (1960) 1246-1258
15. Morgan M.Y., Jakobovits A.W., James I.M., et al. Successful use of bromocriptine in the treatment of chronic hepatic encephalopathy. Gastroenterology 78 (1980) 663-670
16. Philips B.J., Armstrong I.R., Pollock A., et al. Cerebral blood flow and metabolism in patients with chronic liver disease undergoing orthotopic liver transplantation. Hepatology 27 (1998) 369-376
17. Strauss G.I., Møller K., Larsen F.S., et al. Cerebral glucose and oxygen metabolism in patients with fulminant hepatic failure. Liver Transpl 9 (2003) 1244-1252
18. Almdal T., Schroeder T., and Ranek L. Cerebral blood flow and liver function in patients with encephalopathy due to acute and chronic liver diseases. Scand J Gastroenterol 24 (1989) 299-303
19. Kety S.S., and Schmidt C.F. The nitrous oxide method for the quantitative determination of cerebral blood flow in man: theory, procedure and normal values. J Clin Invest 27 (1948) 476-483
20. Kato A., Suzuki K., Kaneta H., et al. Regional differences in cerebral glucose metabolism in cirrhotic patients with subclinical hepatic encephalopathy using positron emission tomography. Hepatol Res 17 (2000) 237-245
21. Lockwood A.H., Yap E.W., Rhoades H.M., et al. Altered cerebral blood flow and glucose metabolism in patients with liver disease and minimal encephalopathy. J Cereb Blood Flow Metab 11 (1991) 331-336
22. Ikeda K., Tsuji H., Azuma K., et al. Alteration of regional cerebral metabolism in patients with cirrhosis in positron emission tomography. [in Japanese]. Fukuoka Igaku Zasshi 92 (2001) 306-314
23. Iversen P., Hansen D.A., Bender D., et al. Peripheral benzodiazepine receptors in the brain of cirrhosis patients with overt hepatic encephalopathy. Eur J Nucl Med Mol Imaging 33 (2006) 810-816
24. Ferenci P., Lockwood A., Mullen K., et al. Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 35 (2002) 716-721
25. Weissenborn K., Ennen J.C., Schomerus H., et al. Neuropsychological characterization of hepatic encephalopathy. J Hepatol 34 (2001) 768-773
26. Elsass P., Christensen S.E., Mortensen E.L., et al. Discrimination between organic and hepatic encephalopathy by means of continuous reaction times. Liver 5 (1985) 29-34
27. Tygstrup N. Determination of the hepatic galactose elimination capacity after a single intravenous injection in man: the reproducibility and the influence of uneven distribution. Acta Physiol Scand 58 (1963) 162-172
28. Tygstrup N. Effect of sites for blood sampling in determination of the galactose elimination capacity. Scand J Clin Lab Invest 37 (1977) 333-338
29. Pugh R.N., Murray-Lyon I.M., Dawson J.L., et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60 (1973) 646-649
30. Thompson C.J., Kecani S., and Boelen S. Evaluation of a neck shield for use during neurological studies with a whole-body PET scanner. IEEE Trans Nucl Sci 48 (2001) 1512-1517
31. van Anken H.C., and Schiphorst M.E. A kinetic determination of ammonia in plasma. Clin Chim Acta 56 (1974) 151-157
32. Munk O.L., Keiding S., and Bass L. A method to estimate catheter dispersion and to calculate dispersion-free blood time-activity curves. Med Phys 35 (2008) 3471-3481
33. Ohta S., Meyer E., Thompson C.J., et al. Oxygen consumption of the living human brain measured after a single inhalation of positron emitting oxygen. J Cereb Blood Flow Metab 12 (1992) 179-192
34. Ohta S., Meyer E., Fujita H., et al. Cerebral [15O]water clearance in humans determined by PET: I. Theory and normal values. J Cereb Blood Flow Metab 16 (1996) 765-780
35. Talairach J., and Tournoux P. Co-planar Stereotactic Atlas of the human brain: 3-dimensional proportional system: an approach to cerebral imaging (1988), Georg Thieme Verlag, Stuttgart, NY
36. Grabner G., Janke A., Budge M., et al. Symmetric atlasing and model based segmentation: an application to the hippocampus in older adults. In: Larsen R., Nielsen M., and Sparring J. (Eds). Medical Image Computing and Computer-Assisted Intervention (2006), Springer, Berlin/Heidelberg, Germany 58-66
37. Collins D.L., Neelin P., Peters T.M., et al. Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space. J Comput Assist Tomogr 18 (1994) 192-205
38. Ribeiro M.J., Almeida P., Strul D., et al. Comparison of fluorine-18 and bromine-76 imaging in positron emission tomography. Eur J Nucl Med 26 (1999) 758-766
39. van der Weerdt A.P., Klein L.J., Boellaard R., et al. Image-derived input functions for determination of MRGlu in cardiac (18)F-FDG PET scans. J Nucl Med 42 (2001) 1622-1629
40. Lawson C.L., and Hanson R.J. Solving least squares problems (1974), Prentice Hall, Englewood Cliffs, NJ
41. Blomqvist G. On the construction of functional maps in positron emission tomography. J Cereb Blood Flow Metab 4 (1984) 629-632
42. Worsley K.J., Liao C.H., Aston J., et al. A general statistical analysis for FMRI data. Neuroimage 15 (2002) 1-15
43. Worsley K.J., Marrett S., Neelin P., et al. A unified statistical approach for determining significant signals in images of cerebral activation. Hum Brain Mapp 4 (1996) 58-73
44. Ahl B., Weissenborn K., van den Hoff J., et al. Regional differences in cerebral blood flow and cerebral ammonia metabolism in patients with cirrhosis. Hepatology 40 (2004) 73-79
45. Borghammer P., Jonsdottir K.Y., Cumming P., et al. Normalization in PET group comparison studies-the importance of a valid reference region. Neuroimage 40 (2008) 529-540
46. Leenders K.L., Perani D., Lammertsma A.A., et al. Cerebral blood flow, blood volume and oxygen utilization. Normal values and effect of age. Brain 113 (1990) 27-47
47. Sakoh M., Ostergaard L., Røhl L., et al. Relationship between residual cerebral blood flow and oxygen metabolism as predictive of ischemic tissue viability: sequential multitracer positron emission tomography scanning of middle cerebral artery occlusion during the critical first 6 hours after stroke in pigs. J Neurosurg 93 (2000) 647-657
48. Ahboucha S., and Butterworth R. Pathophysiology of hepatic encephalopathy: a new look at GABA from the molecular standpoint. Metab Brain Dis 19 (2004) 331-343